PapersPMID:21544882
Effect of Salvia miltiorrhiza hydrophilic extract on antioxidant enzymes in diabetic patients with chronic heart disease: a randomized controlled trial.
- findings
- 3
- compound
- 1
- endpoints
- 3
- Study, every finding
- RCT
- Dose studied, every finding
- dose and route of administration not stated in the abstract, given on top of hypoglycemic therapy
What moved
How to read these marks →- Decreases malondialdehyde (circulating)
very limited
“Overall, the malondialdehyde (MDA) level at day 30 in the treatment group was significantly lower than in the placebo group.”
- Duration
- 4 weeks
- Population
- Diabetic patients with chronic heart disease; hypoglycemic therapy given to both arms, hydrophilic extract added in the treatment arm; day 30 timepoint only
“At day 60, the serum glutathione (GSH) level, superoxide dismutase (SOD), Paraoxonase (PONase) and glutathione reductase (GSSG-R) activities increased markedly in the treatment group compared with the placebo group.”
- Increases superoxide dismutase activity
very limited
- Duration
- 2 months
- Population
- Diabetic patients with chronic heart disease; hypoglycemic therapy given to both arms, hydrophilic extract added in the treatment arm; day 60 timepoint
- Increases serum paraoxonase-1 (PON1) activity
very limited
- Duration
- 2 months
- Population
- Diabetic patients with chronic heart disease; hypoglycemic therapy given to both arms, hydrophilic extract added in the treatment arm; day 60 timepoint
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Diabetic patients with chronic heart disease (CHD); Salvia miltiorrhiza hydrophilic extract (SMHE) given on top of hypoglycemic therapy
- Participants
- 62
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 7